<bill session="100" type="h" number="3459" updated="2014-03-22T09:52:50-04:00">
  <state datetime="1988-04-18">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="1988-04-18"/>
  </status>
  <introduced datetime="1987-10-09"/>
  <titles>
    <title type="short" as="introduced">Orphan Drug Amendments of 1987</title>
    <title type="short" as="reported to house">Orphan Drug Amendments of 1987</title>
    <title type="short" as="passed house">Orphan Drug Amendments of 1988</title>
    <title type="short" as="enacted">Orphan Drug Amendments of 1988</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to revise the provisions respecting orphan drugs and for other purposes.</title>
  </titles>
  <sponsor id="400425"/>
  <cosponsors/>
  <actions>
    <action datetime="1987-10-09" state="REFERRED">
      <text>Referred to House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="1987-10-09">
      <text>For Previous Action See H.R.3349.</text>
    </action>
    <action datetime="1987-10-14">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="1987-10-14" state="REPORTED">
      <text>Ordered to be Reported (Amended).</text>
    </calendar>
    <action datetime="1987-12-10">
      <text>Reported to House (Amended) by House Committee on Energy and Commerce.  Report No: 100-473.</text>
    </action>
    <action datetime="1987-12-10">
      <text>Placed on Union Calendar No: 300.</text>
    </action>
    <action datetime="1988-03-22">
      <text>Called up by House Under Suspension of Rules.</text>
    </action>
    <vote how="roll" type="vote" roll="40" datetime="1988-03-22" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>Passed House (Amended) by Yea-Nay Vote: 409 - 1 (Record Vote No: 40).</text>
    </vote>
    <calendar datetime="1988-03-24" calendar="Senate Legislative" under="General Orders" number="601">
      <text>Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 601.</text>
    </calendar>
    <vote how="by Voice Vote" type="vote2" datetime="1988-03-31" where="s" result="pass" state="PASSED:BILL">
      <text>Passed Senate without amendment by Voice Vote.</text>
    </vote>
    <topresident datetime="1988-03-31">
      <text>Cleared for White House.</text>
    </topresident>
    <action datetime="1988-04-11">
      <text>Measure Signed in Senate.</text>
    </action>
    <topresident datetime="1988-04-12">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="1988-04-18" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="100-290" type="public" datetime="1988-04-18">
      <text>Became Public Law No: 100-290.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, Markup, Reporting"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="100" type="h" number="3349"/>
  </relatedbills>
  <subjects>
    <term name="Drugs"/>
    <term name="Advisory bodies"/>
    <term name="Drug industry"/>
    <term name="Drug law and legislation"/>
    <term name="Drug safety and regulation"/>
    <term name="Drugs and narcotics"/>
    <term name="Federal advisory bodies"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Licenses"/>
    <term name="Medical research"/>
    <term name="Medical supplies"/>
    <term name="Pharmaceutical research"/>
    <term name="Research"/>
    <term name="Tax credits"/>
  </subjects>
  <amendments/>
  <summary>3/22/1988--Passed House amended.
(Measure passed House, amended, roll call #40 (409-1)) Orphan Drug Amendments of 1988 - Amends the Federal Food, Drug, and Cosmetic Act to require requests for designation as an orphan drug to be made before the submission of an application. Requires manufacturers of orphan drugs which have been approved, certified, or licensed to notify the Secretary of Health and Human Services at least one year before discontinuing the production of the drug. Requires manufacturers or sponsors of an orphan drug which has not been approved, certified, or licensed while investigations are being conducted to notify the Secretary of any decision to discontinue pursuit of approval. Makes financial assistance available for the development of medical devices and medical foods for rare diseases or conditions. Authorizes appropriations for FY 1988 through 1990. Directs the Secretary to study and report to the appropriate congressional committees on whether the application of the provisions of the Federal Food, Drug, and Cosmetic Act relating to drugs for rare diseases and conditions and the Internal Revenue Code relating to tax credits is needed to encourage the development of such medical devices and foods for rare diseases and conditions. Extends until February 1, 1989, the National Commission on Orphan Diseases' report to the Congress on the National Institutes of Health's work in the area or rare diseases and conditions.</summary>
</bill>
